Different liposomal amphotericin B formulations for visceral leishmaniasis

Lancet Glob Health. 2014 Aug;2(8):e449. doi: 10.1016/S2214-109X(14)70252-9. Epub 2014 Jul 23.

Authors

Thomas P C Dorlo¹, Manica Balasegaram²

Affiliations

¹ Department of Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, Netherlands. Electronic address: t.p.c.dorlo@uu.nl.
² Médecins Sans Frontières' Access Campaign, Geneva, Switzerland.

PMID: 25103515
DOI: 10.1016/S2214-109X(14)70252-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Amphotericin B / administration & dosage*
Antiprotozoal Agents / administration & dosage*
Female
Humans
Leishmaniasis, Visceral / drug therapy*
Male

Substances

Antiprotozoal Agents
Amphotericin B